The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.

Hongxia LiLei ZhangMing XiaChi ZhangTingbo Jiang

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

Conventional coagulation assays are suboptimal for assessing the coagulation status of dabigatran. TG could be used as supplementary assays to evaluate the anticoagulation effect of oral anticoagulants. Our results suggest that warfarin may inhibit TG more aggressively than dabigatran in patients regardless of age and kidney function.

Keyphrases

atrial fibrillation
oral anticoagulants
left atrial
catheter ablation
direct oral anticoagulants
left atrial appendage
heart failure
end stage renal disease
percutaneous coronary intervention
newly diagnosed
high throughput
chronic kidney disease
patient reported outcomes
acute coronary syndrome
patient reported